Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 16 studies | 37% ± 20% | |
lung | 13 studies | 26% ± 10% | |
peripheral blood | 13 studies | 26% ± 11% | |
eye | 9 studies | 27% ± 8% | |
kidney | 6 studies | 19% ± 3% | |
intestine | 5 studies | 27% ± 11% | |
bone marrow | 4 studies | 25% ± 8% | |
heart | 4 studies | 20% ± 2% | |
lymph node | 4 studies | 22% ± 6% | |
liver | 4 studies | 35% ± 17% | |
adipose | 4 studies | 22% ± 2% | |
pancreas | 3 studies | 26% ± 10% | |
uterus | 3 studies | 38% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 5303.96 | 459 / 459 | 100% | 45.96 | 1118 / 1118 |
esophagus | 100% | 5163.04 | 1445 / 1445 | 100% | 33.68 | 183 / 183 |
ovary | 100% | 7887.52 | 180 / 180 | 100% | 34.48 | 430 / 430 |
uterus | 100% | 6472.42 | 170 / 170 | 100% | 47.79 | 459 / 459 |
brain | 100% | 5076.12 | 2638 / 2642 | 100% | 33.93 | 705 / 705 |
prostate | 100% | 5074.78 | 245 / 245 | 100% | 35.10 | 501 / 502 |
bladder | 100% | 5696.71 | 21 / 21 | 100% | 33.08 | 502 / 504 |
thymus | 100% | 5303.53 | 653 / 653 | 100% | 39.60 | 602 / 605 |
lung | 99% | 4812.34 | 574 / 578 | 100% | 48.09 | 1153 / 1155 |
kidney | 100% | 4056.13 | 89 / 89 | 99% | 27.32 | 891 / 901 |
intestine | 100% | 5112.40 | 966 / 966 | 99% | 22.45 | 521 / 527 |
stomach | 100% | 4103.98 | 359 / 359 | 99% | 22.12 | 282 / 286 |
skin | 100% | 5622.26 | 1806 / 1809 | 99% | 44.65 | 466 / 472 |
pancreas | 99% | 3544.45 | 325 / 328 | 99% | 27.84 | 177 / 178 |
adrenal gland | 100% | 6424.95 | 258 / 258 | 98% | 28.19 | 226 / 230 |
liver | 99% | 2357.31 | 224 / 226 | 99% | 21.43 | 400 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 36.46 | 29 / 29 |
muscle | 100% | 31160.93 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 4192.15 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 50.80 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 11.94 | 1 / 1 |
blood vessel | 100% | 5565.48 | 1334 / 1335 | 0% | 0 | 0 / 0 |
adipose | 100% | 5715.11 | 1203 / 1204 | 0% | 0 | 0 / 0 |
heart | 97% | 5872.57 | 833 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 94% | 27.21 | 75 / 80 |
peripheral blood | 75% | 3210.40 | 699 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0099577 | Biological process | regulation of translation at presynapse, modulating synaptic transmission |
GO_0140694 | Biological process | non-membrane-bounded organelle assembly |
GO_0051664 | Biological process | nuclear pore localization |
GO_0048170 | Biological process | positive regulation of long-term neuronal synaptic plasticity |
GO_0043488 | Biological process | regulation of mRNA stability |
GO_0051028 | Biological process | mRNA transport |
GO_0021542 | Biological process | dentate gyrus development |
GO_0061157 | Biological process | mRNA destabilization |
GO_0051292 | Biological process | nuclear pore complex assembly |
GO_0051966 | Biological process | regulation of synaptic transmission, glutamatergic |
GO_0048513 | Biological process | animal organ development |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0007517 | Biological process | muscle organ development |
GO_0045727 | Biological process | positive regulation of translation |
GO_0006915 | Biological process | apoptotic process |
GO_0045187 | Biological process | regulation of circadian sleep/wake cycle, sleep |
GO_1900272 | Biological process | negative regulation of long-term synaptic potentiation |
GO_0060538 | Biological process | skeletal muscle organ development |
GO_0050767 | Biological process | regulation of neurogenesis |
GO_0032720 | Biological process | negative regulation of tumor necrosis factor production |
GO_1902373 | Biological process | negative regulation of mRNA catabolic process |
GO_0007286 | Biological process | spermatid development |
GO_0017148 | Biological process | negative regulation of translation |
GO_2000637 | Biological process | positive regulation of miRNA-mediated gene silencing |
GO_0005730 | Cellular component | nucleolus |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0098793 | Cellular component | presynapse |
GO_0043197 | Cellular component | dendritic spine |
GO_0005840 | Cellular component | ribosome |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0016020 | Cellular component | membrane |
GO_0043034 | Cellular component | costamere |
GO_0036464 | Cellular component | cytoplasmic ribonucleoprotein granule |
GO_0005635 | Cellular component | nuclear envelope |
GO_0043005 | Cellular component | neuron projection |
GO_0005829 | Cellular component | cytosol |
GO_0043232 | Cellular component | intracellular non-membrane-bounded organelle |
GO_0005737 | Cellular component | cytoplasm |
GO_0030424 | Cellular component | axon |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0045182 | Molecular function | translation regulator activity |
GO_0140693 | Molecular function | molecular condensate scaffold activity |
GO_0033592 | Molecular function | RNA strand annealing activity |
GO_0035925 | Molecular function | mRNA 3'-UTR AU-rich region binding |
GO_0003723 | Molecular function | RNA binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0003730 | Molecular function | mRNA 3'-UTR binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FXR1 |
Protein name | FMR1 autosomal homolog 1 RNA-binding protein FXR1 (FMR1 autosomal homolog 1) (hFXR1p) FXR1 protein Fragile X mental retardation autosomal homolog variant p1K FMR1 autosomal homolog 1 (cDNA FLJ58644, highly similar to Fragile X mental retardation syndrome-related protein 1) RNA-binding protein FXR1 |
Synonyms | hCG_2021334 |
Description | FUNCTION: mRNA-binding protein that acts as a regulator of mRNAs translation and/or stability, and which is required for various processes, such as neurogenesis, muscle development and spermatogenesis . Specifically binds to AU-rich elements (AREs) in the 3'-UTR of target mRNAs . Promotes formation of some phase-separated membraneless compartment by undergoing liquid-liquid phase separation upon binding to AREs-containing mRNAs, leading to assemble mRNAs into cytoplasmic ribonucleoprotein granules that concentrate mRNAs with associated regulatory factors (By similarity). Required to activate translation of stored mRNAs during late spermatogenesis: acts by undergoing liquid-liquid phase separation to assemble target mRNAs into cytoplasmic ribonucleoprotein granules that recruit translation initiation factor EIF4G3 to activate translation of stored mRNAs in late spermatids (By similarity). Promotes translation of MYC transcripts by recruiting the eIF4F complex to the translation start site . Acts as a negative regulator of inflammation in response to IL19 by promoting destabilization of pro-inflammatory transcripts . Also acts as an inhibitor of inflammation by binding to TNF mRNA, decreasing TNF protein production (By similarity). Acts as a negative regulator of AMPA receptor GRIA2/GluA2 synthesis during long-lasting synaptic potentiation of hippocampal neurons by binding to GRIA2/GluA2 mRNA, thereby inhibiting its translation (By similarity). Regulates proliferation of adult neural stem cells by binding to CDKN1A mRNA and promoting its expression (By similarity). Acts as a regulator of sleep and synaptic homeostasis by regulating translation of transcripts in neurons (By similarity). Required for embryonic and postnatal development of muscle tissue by undergoing liquid-liquid phase separation to assemble target mRNAs into cytoplasmic ribonucleoprotein granules . Involved in the nuclear pore complex localization to the nuclear envelope by preventing cytoplasmic aggregation of nucleoporins: acts by preventing ectopic phase separation of nucleoporins in the cytoplasm via a microtubule-dependent mechanism . . |
Accessions | ENST00000484790.5 Q14341 E9PFF5 C9JZE0 ENST00000480918.5 C9JAJ4 B4DXZ6 C9J5B4 A0A0F7L1S3 ENST00000445140.6 [P51114-2] C9JYQ6 ENST00000305586.11 [P51114-3] P51114 ENST00000469882.5 A0A8V8TMQ1 ENST00000357559.9 [P51114-1] ENST00000468861.5 A0A8V8TNP6 ENST00000491674.1 A0A0F7KYT8 C9IZ22 ENST00000491062.5 ENST00000465551.5 A0A8V8TM97 ENST00000484042.1 H7C4S4 ENST00000484958.5 ENST00000475315.5 C9JY20 A0A0F7L0Q8 ENST00000698794.1 A0A0F7L2Z7 ENST00000698793.1 ENST00000482125.1 E7EU85 |